China’s health regulators have granted approvals for a string of brain-technology products this year. These devices, which allow patients to control digital devices using thought alone, are designed to transform the treatment of conditions ranging from paraplegia to Alzheimer’s and depression. The move is part of Beijing's broader effort to lead the world in brain-computer interfaces, offering generous policy support to help domestic firms compete with overseas players such as Elon Musk’s ventures.